Changeflow GovPing Healthcare Analyte sensor devices, connections, and methods
Routine Rule Added Final

Analyte sensor devices, connections, and methods

Favicon for changeflow.com ChangeBridge: Patent Grants - Diagnosis & Surgery (A61B)
Published March 24th, 2026
Detected March 27th, 2026
Email

Summary

The USPTO has granted patent US12582334B2 to Abbott Diabetes Care Inc. for analyte sensor devices, connections, and methods. The patent covers on-body analyte sensor units, packaging, loading systems, and applicators, as well as novel connection approaches for electrochemical analyte sensors.

What changed

The United States Patent and Trademark Office (USPTO) has issued patent US12582334B2 to Abbott Diabetes Care Inc. This patent grants exclusive rights for "Analyte sensor devices, connections, and methods," specifically detailing innovations in on-body analyte sensor units, including packaging, loading systems, and applicators. It also covers unique methods for connecting electrochemical analyte sensors, facilitating the assembly of separate electronic and sensor components.

While this is a patent grant and not a regulatory rule imposing direct compliance obligations, it signifies a new intellectual property right in the medical device sector. Companies operating in the diabetes care and analyte sensing space, particularly those developing or manufacturing similar devices, should be aware of this patent to avoid potential infringement. The patent's effective date is March 24, 2026, and it was filed on November 2, 2022.

Source document (simplified)

← USPTO Patent Grants

Analyte sensor devices, connections, and methods

Grant US12582334B2 Kind: B2 Mar 24, 2026

Assignee

ABBOTT DIABETES CARE INC.

Inventors

Louis Pace, Peter G. Robinson, Udo Hoss, Samuel Mason Curry, Phillip William Carter, Vincent Michael DiPalma, Amit Mhatre, Jennifer Olson, Manuel Luis Miguel Donnay, Marc Barry Taub

Abstract

Devices associated with on-body analyte sensor units are disclosed. These devices include any of packaging and/or loading systems, applicators and elements of the on-body sensor units themselves. Also, various approaches to connecting electrochemical analyte sensors to and/or within associated on-body analyte sensor units are disclosed. The connector approaches variously involve the use of unique sensor and ancillary element arrangements to facilitate assembly of separate electronics assemblies and sensor elements that are kept apart until the end user brings them together.

CPC Classifications

A61B 5/14503 A61B 5/0002 A61B 5/14532

Filing Date

2022-11-02

Application No.

17979330

Claims

26

View original document →

Named provisions

Analyte sensor devices, connections, and methods

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
USPTO
Published
March 24th, 2026
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12582334B2

Who this affects

Applies to
Drug manufacturers Medical device makers
Industry sector
3345 Medical Device Manufacturing 3254 Pharmaceutical Manufacturing
Activity scope
Medical Device Development Product Manufacturing
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Product Development
Topics
Healthcare Technology Pharmaceuticals

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - Diagnosis & Surgery (A61B) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.